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Abstract
The phenotypic plasticity of cancer cells has received special attention in recent years.
Even though related models have been widely studied in terms of mathematical properties,
a thorough statistical analysis on parameter estimation and model selection is still very
lacking. In this study, we present a Bayesian approach on the relative frequencies of
cancer stem cells (CSCs). Both Gibbs sampling and Metropolis-Hastings (MH) algorithm
are used to perform point and interval estimations of cell-state transition rates between
CSCs and non-CSCs. Extensive simulations demonstrate the validity of our model and
algorithm. By applying this method to a published data on SW620 colon cancer cell
line, the model selection favors the phenotypic plasticity model, relative to conventional
hierarchical model of cancer cells. Moreover, it is found that the initial state of CSCs after
cell sorting significantly influences the occurrence of phenotypic plasticity.
1 Introduction
The hypothesis of cancer stem cell theory [1, 2] postulates a hierarchical organization
of cancer cells. A small number of tumorigenic cancer cells, also termed cancer stem
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cells (CSCs), reside at the apex of this cellular hierarchy [3]. CSCs are capable of self-
renewal and generating more differentiated cancer cells with lower tumorigenic potential.
However, growing researches have extended the CSC model by proposing a phenotypic
plasticity paradigm in which reversible transitions could happen between CSCs and non-
CSCs [4]. That is, not only can CSCs give rise to non-CSCs, but a fraction of non-CSCs
can reacquire CSC-like characteristics. This de-differentiation from non-CSCs to CSCs
has been reported in quite a few types of cancer, such as breast cancer [5, 6, 7], melanoma
[8], colon cancer [9], and glioblastoma multiforme [10].
Very recently special attention has been paid to reasonable mathematical models for
quantifying the process of phenotypic plasticity. In particular, it was found that the
phenotypic plasticity plays an important role in the stability of the quantitative models
[6, 11, 12, 13, 14, 15, 16]. That is, the phenotypic plasticity greatly contributes to stabi-
lizing the phenotypic mixture of cancer cells, thereby effectively maintaining the hetero-
geneity of cancer cell populations. Some other researches laid emphasis on the role of the
phenotypic plasticity in transient dynamics. It was shown that an interesting overshoot
phenomenon of CSCs observed in experiment can be well explained by de-differentiation
from non-CSCs to CSCs [17, 18]. Besides, Leder et al studied mathematical models
of pdgf-driven glioblastoma and revealed that the effectiveness of radiotherapy is quite
sensitive to the capability of de-differentiation from differentiated sensitive cells to stem-
like resistant cells [19]; Jilkine and Gutenkunst studied the effect of de-differentiation
on time to mutation acquisition in cancers [20]; Chen et al studied transition model be-
tween endocrine therapy responsive and resistant states in breast cancer by Landscape
Theory [21]; Dhawan et al showed with mathematical modeling that exposure to hypoxia
enhanced the plasticity and heterogeneity of cancer cell populations [22]; Tonekaboi et
al investigated how cellular plasticity behaves differently in small and large cancer cell
populations [23]. A recent review by Jolly et al [24] focused on quantitative models of
Epithelial-mesenchymal plasticity in cancer.
Even though the phenotypic plasticity has been extensively studied in terms of math-
ematical properties, the statistical analysis on parameter estimation and model selection
is still very lacking. Actually, one of the crucial tasks in the research of phenotypic
plasticity is to estimate the transition rates between different cell types. As a pioneer-
ing work, Gupta et al [6] established a discrete-time Markov state transition model and
estimated the transition probabilities between different cell states by fitting the model to
their FACS (Fluorescence-activated cell sorting) data on SUM159 and SUM149 breast
cancer cell lines. Besides, continuous-time ordinary differential equations (ODEs) mod-
els were also developed [13, 14], based on which de-differentiation rates were estimated
by fitting to SW620 colon cancer cell line. However, the above mentioned works can
only provide point estimations to the interested parameters, but not interval estimations.
Comparatively, interval estimation is much more informative and frequently-used than
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point estimation in practice. For doing interval estimation, statistical modeling rather
than deterministic modeling should be applied. Moreover, note that it is still question-
able if de-differentiation is a crucial improvement to the cellular hierarchy of cancer cells
or just a minor extension to it, model selection can be used to validate the paradigm of
phenotypic plasticity in terms of statistical significance. Therefore, a thorough statisti-
cal analysis is of great value for further quantifying the biological process of phenotypic
plasticity and exploring its biological significance.
In this research, a statistical framework is presented to analyze a two-phenotypic
model of cancer cells. In this model, each cancer cell is either CSC phenotypic state
or non-CSC phenotypic state. Both types of cells can divide symmetrically or asymmetri-
cally with certain probabilities. A Bayesian approach [25] is developed to fit this model to
experimental data on relative frequencies of CSCs. MCMC methods (such as Gibbs sam-
pling [26] and MH algorithm [27, 28]) are used to perform statistical inference with Mul-
tivariate Potential Scale Reduction Factor (MPSRF) [29, 30] checking the convergence
of MCMC chains. Our simulation results demonstrate the precision and accuracy of our
algorithm by both point estimation and interval estimation. By applying our approach to a
published data on SW620 colon cancer cell line [9], we also perform model selection via
deviance information criterion (DIC, [31]). Our result shows that the phenotypic plasticity
model with de-differentiation has superior quality relative to the hierarchical model with-
out de-differentiation. Furthermore, an interesting frequency-dependent phenomenon is
presented, i.e. the estimated values of the model parameters depend on the initial relative
frequencies of different cell states. This suggests that the process of phenotypic plasticity
could be relevant to the heterogeneity level of cancer cell populations.
The paper is organized as follows. The model assumptions and Bayesian framework
are presented in Section 2. Main results including simulations and real data analysis are
shown in Section 3. Conclusions are presented in Section 4.
2 Methods
2.1 Model assumptions
In this section we describe the model assumptions. Note that the salient feature of the phe-
notypic plasticity model is the reversibility between CSCs and non-CSCs, i.e., not only
can CSCs differentiate into non-CSCs, but non-CSCs are also capable of de-differentiating
into CSCs. Consider a population of cancer cells comprising two phenotypes: CSC
represents cancer stem cell phenotypic state, non-CSC represents non-stem cancer cell
phenotypic state. Even though this two-phenotypic assumption simplifies the biological
complexity of highly diverse phenotypes in cancer, the two-phenotypic setting has been
proved as an effective and reasonable simplification for highlighting the minimal process
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of phenotypic plasticity [11, 12, 13, 19]. Similar bidirectional transition cascade models
were also studied in bacterial community [32, 33].
We now present the cellular process of the two-phenotypic model. From probabilistic
point of view, this model can be seen as a discrete-time two-type branching process [34].
Each cell lives for a fixed time (suppose one unit of time). At the moment of death it gives
birth to two daughter cells. More specifically, for each CSC, it gives birth to two identical
CSC daughter cells with probability α (symmetric division), otherwise (with probability
1−α) it gives birth to one CSC daughter cell and one non-CSC daughter cell (asymmetric
division). For each non-CSC, it divides symmetrically into two non-CSC daughter cells
with probability 1 − β, whereas it divides asymmetrically into one non-CSC daughter
cell and one CSC daughter cell with probability β (de-differentiation). The model will
reduce to conventional hierarchical model if letting β = 0, i.e. de-differentiation is not
allowed to happen. Hence the model selection with respect to β provides an efficient way
to evaluate the significance of phenotypic plasticity.
The statistical inference of branching processes has been studied for a long time [35].
The usage of statistical methods strongly depends on the data types available. Normally,
the observation of the whole genealogy tree generated from underlying process is quite
difficult to obtain (except in very limited experiments [36]). Instead, only can the numbers
or relative frequencies of distinct cell types be recorded at given moment, and compar-
atively it is easier to collect data on relative frequencies than absolute numbers of given
cell types [37]. Thus developing statistical approaches for proportion data has a wider
range of application. In this work our proposed method is used for the time-series data on
relative frequencies of CSC phenotypic state.
Let xA(t) be the frequency of CSC state at time t, µt be the expectation of xA(t), i.e.
µt = E(xA(t)), and σ
2
t be the variance of xA(t), i.e. σ
2
t = Var(xA(t)). Then we can
obtain two important recurrence formulas as follows (see A for more details):
µt+1 =
1 + α− β
2
µt +
β
2
, (1)
σ2t+1 = (
1 + α− β
2
)2σ2t +
1
N0 × 2t+2
{[α(1− α)− β(1− β)]µt + β(1− β)} , (2)
where N0 is the initial number of the whole population. In next section, we will put
forward a Bayesian statistical framework based on the above two formulas.
2.2 Bayesian framework
The data we deal with looks like {(m0, v0), (m1, v1), · · · , (mt, vt), · · · (mT , vT )}, where
mt and vt are sample mean and sample variance of n realizations of xA(t) respectively.
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The Markov property of the model implies that the distribution of data at time t only
depends on data at time t− 1. Thus, we can write the joint likelihood of data as follows:
L(α, β|m0, v0, m1, v1, · · · , mT , vT ) = f(m0, v0)×f(m1, v1|m0, v0, α, β)×· · ·×f(mT , vT |mT−1, vT−1, α, β).
Note that f(m0, v0) is irrelevant to the parameters α and β, the joint likelihood can be
expressed as
L(α, β|m0, v0, m1, v1, · · · , mT , vT ) ∝ f(m1, v1|m0, v0, α, β)×· · ·×f(mT , vT |mT−1, vT−1, α, β).
According to the asymptotic normality of xA(t) provided N0 ≫ 1 (see Theorem 1 in
[37]), the asymptotic distributions ofmt and vt can be given as:
mt ∼ N(µt,
σ2t
n
),
vt ∼
σ2t
n− 1
χ2(n− 1).
Since mt, vt are unbiased estimators of µt, σ
2
t respectively, we can substitute µt and σ
2
t
with the corresponding observed sample mean mt and sample variance vt in the recur-
rence formulas (1) and (2). Given the priors of α, β as Beta(1, 1), i.e. uniform distribu-
tion, we can obtain the following posterior distribution:
p(α, β|m0, v0, m1, v1 · · · , mT , vT ) = L(α, β|m0, v0, m1, v1, · · · , mT , vT )× p(α)× p(β)
∝
T−1∏
t=0


[(
1 + α− β
2
)2
vt +
1
N0 × 2t+2
{[α(1− α)− β(1− β)]mt + β(1− β)}
]
−
n
2
v
n−3
2
t+1

×
exp
{
−
1
2
T−1∑
t=0
n(mt+1 −
1+α−β
2
mt −
β
2
)2
(1+α−β
2
)2vt +
1
N0×2t+2
{[α(1− α)− β(1− β)]mt + β(1− β)}
+
(n− 1)vt+1
(1+α−β
2
)2vt +
1
N0×2t+2
{[α(1− α)− β(1− β)]mt + β(1− β)}
}
Note that N0 ≫ 1, the above posterior distribution can be revised as the following sim-
plified expression:
p(α, β|m0, v0, m1, v1 · · · , mT , vT ) ∝
T−1∏
t=0


[(
1 + α− β
2
)2
vt
]
−
n
2
v
n−3
2
t+1

×
exp
{
−
1
2
T−1∑
t=0
n(mt+1 −
1+α−β
2
mt −
β
2
)2
(1+α−β
2
)2vt
+
(n− 1)vt+1
(1+α−β
2
)2vt
}
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We will show in Section 3.2 that N0 does has little impact on the simulation results, and
then validate the above simplified posterior distribution.
Based on the proposed posterior distribution, α and β are sampled iteratively by Gibbs
sampling and MH algorithm. We draw several sample chains independently and apply
MPSRF [29, 30] to check the convergence of MCMC chains. If the MCMC chains con-
verge, we obtain the point estimation and interval estimation as mean value and interval
between 2.5% and 97.5% quantiles of converged posterior samples respectively.
3 Results
In this section we perform some simulations to validate our algorithm and also apply our
method to a published data set of SW620 colon cancer cell line [9].
3.1 Simulation I
In the first simulation, we generate synthesized data sets to test the performance of our
algorithm. In particular, we setN0 = 10
4 and generate parameters α and β from their pri-
ors respectively, drawing mean value m0 from Unif(0.3, 0.7) and standard deviance v
1
2
0
from Unif(0.01, 0.03). We then synthesize {m1, v1}, · · · , {mT , vT} sequentially based
on the conditional distribution function in Section 2.2. In all we generate 100 groups
of parameters and each group consists of 20 simulations. Table 1 demonstrates the esti-
mation results including Mean Square Error (MSE) of point estimation, averaged length
of 95% confidence intervals (AL) and mean proportion of interval estimation covering
the true value of parameters (CR). It is easy to find that our algorithm is accurate for the
α β
MSE AL CR MSE AL CR
0.0004 0.0414 0.924 0.0003 0.0321 0.917
Table 1: Estimation results of Simulation I.
synthesized data sets, with small MSE, high coverage rate and narrow confidence interval.
3.2 Simulation II
In the second simulation, we generate data sets by following the cellular processes of the
two-phenotypic model described in Section 2.1 to validate our method. We set N0 = 10
4
and randomly generate the true values of parameters α and β from their priors. Given
each value of (α, β) and initial state xA(0) sampled from a Normal distributionN(µ
′, σ′2)
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with µ′ ∼ Unif(0.3, 0.7) and σ′ ∼ Unif(0.01, 0.03), we generate n = 5 synthesized
realizations of xA(t) and then calculate the sample mean mt and sample variance vt as
algorithm input. In all we generate 100 groups of parameters (α, β) with each consisting
of 20 simulations. Table 2 demonstrates the MSE, AL and CR of two methods with and
without N0 as known true value. From the table, we can see that our algorithm well
Set
α β
MSE AL CR MSE AL CR
With N0 0.0004 0.0380 0.979 0.0002 0.0302 0.979
WithoutN0 0.0006 0.0378 0.962 0.0003 0.0296 0.963
Table 2: Estimation results of Simulation II.
captures the cellular process when only mean and variance data are available. Both point
estimation and interval estimation achieve high accuracy even if N0 is unknown in our
algorithm. An example of estimation results can be found in B.
3.3 Real data
Our real data application is based on a published data of SW620 colon cancer cell line
(see Figure 4A in [9]). There are four groups of data in this experiment. In each group,
CSC proportions were measured via FACS (Fluorescence-activated cell sorting), and both
sample meanmt and sample variance vt were recorded successively. The four groups dif-
fer in the initial states of relative frequencies: (A) 0.6% CSCs and 99.4% non-CSCs;
(B) 70% CSCs and 30% non-CSCs; (C) 99.4% CSCs and 0.6% non-CSCs; (D) 65.4%
CSCs and 34.6% non-CSCs. We assume four sets of parameters Θ1 = {α1, β1},Θ2 =
{α2, β2},Θ3 = {α3, β3},Θ4 = {α4, β4} corresponding to four groups of data and per-
form model selection by calculating Deviance information criterion (DIC, [31]). As a
generalization of Akaike information criterion (AIC) and Bayesian information criterion
(BIC), DIC is also an estimator of the relative quality of statistical models for given data,
and it is particularly useful in Bayesian statistical settings, representing the trade-off be-
tween the error of fitting and the complexity of the model. The smaller the DIC is, the
more favorable the model is.
Our primary concern is whether the hypothesis of reversible phenotypic plasticity is
superior to the hypothesis of cellular hierarchy given the colon cancer data. Note that
the phenotypic plasticity model will reduce to the hierarchical model by setting βi =
0 (i = 1, 2, 3, 4). We would like to compare the DIC values between the full model
and the hierarchical model without de-differentiation. Our result shows that the DIC
value of the full model is −103.23, which is smaller than that of the hierarchical model
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without de-differentiation (−84.05). Model selection thus suggests that de-differentiation
significantly improve the quality of the model for the given data.
Furthermore, we are interested in whether some of the four groups of data share the
common values of the parameters, from which we can see the dependency of the param-
eters on the initial states. The DIC values of different models are shown in Table 3 (see
C for the estimated values of the parameters). From the table, we can find that models
Θ1 6= Θ2 6= Θ3 6= Θ4 and Θ1 = Θ2 obtain the smallest DIC values, which means these
two models are favorable. Due to the limited data length, these two models cannot be
distinguished since the difference between their DIC values is only about 0.15, without
statistical significance. It is interesting that the model Θ1 6= Θ2 6= Θ3 6= Θ4 is selected as
the favorable model. That is, none of the four groups share the common parameters, all
the parameters are sensitive to the initial states of relative frequencies. Note that different
initial relative frequencies correspond to different states of phenotypic heterogeneity at
the beginning of cell sorting, our result suggests an interesting heterogeneity-dependency
of the phenotypic plasticity model.
Model DIC
Θ1 6= Θ2 6= Θ3 6= Θ4 -103.23
Θ1 = Θ2 -103.38
Θ1 = Θ3 7.03
Θ1 = Θ4 -90.00
Θ2 = Θ3 125.37
Θ2 = Θ4 -82.37
Θ3 = Θ4 71.72
Θ1 = Θ2,Θ3 = Θ4 71.57
Θ1 = Θ3,Θ2 = Θ4 27.89
Θ1 = Θ4,Θ2 = Θ3 138.60
Θ2 = Θ3 = Θ4 173.39
Θ1 = Θ3 = Θ4 96.39
Θ1 = Θ2 = Θ4 -83.58
Θ1 = Θ2 = Θ3 146.96
Θ1 = Θ2 = Θ3 = Θ4 189.42
Table 3: DIC of Bayesian model selection.
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4 Conclusions
We have presented a Bayesian statistical analysis on a stochastic phenotypic plasticity
model of cancer cells. Both simulation studies and real data analysis have shown the
power of our method. Compared to the deterministic models in previous studies [14, 13],
the stochastic model here equipping with statistical inference makes quantitative model-
ing in a more sophisticated way. On one hand, parameter estimation is extended from
point-level into interval-level. On the other hand, model selection provides a system-
atic means to compare different models, and then helps to evaluate different biological
hypotheses.
It should be noted that, the two-phenotypic model is a very simplified model. By
focusing on our attention to the reversibility between CSCs and non-CSCs, many biolog-
ically complex mechanisms are not included in this model. For example, the model is
discrete-time, ignoring the complicated time distribution of cell cycle [38, 39, 40]. Devel-
oping feasible Bayesian framework for more complicated models could be of great value
in future researches.
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A Derivation of Eqs. (1) and (2)
Here we present the mathematical details of how to obtain Eqs. (1) and (2), i.e. the
recurrence formulas of the expectation and variance of xA(t).
Let nA(t) and nB(t) are the numbers of CSC and non-CSC states, xA(t) and xB(t) are
the frequencies of CSC and non-CSC states,N(t) is the population size of the whole pop-
ulation. It is easy to know that xA(t) = 1−xB(t), xA(t) = nA(t)/N(t) = nA(t)/(nA(t)+
nB(t)), and xB(t) = nB(t)/N(t). Suppose
ξi =
{
1, with probability α
0, with probability 1− α
ηi =
{
1, with probability β
0, with probability 1− β,
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then we have
nA(t+ 1) = nA(t) +
nA(t)∑
i=1
ξi +
nB(t)∑
i=1
ηi.
By taking conditional expectation on both sides we have
E(nA(t+ 1)|nA(t)) = nA(t) + nA(t)× α + nB(t)× β.
Then for the conditional expectation of xA(t) we have
E(xA(t+ 1)|xA(t)) = E(
nA(t + 1)
N(t + 1)
|xA(t))
= E(
nA(t + 1)
2N(t)
|xA(t))
=
1
2
1
N(t)
(nA(t) + nA(t)× α + nB(t)× β)
=
1
2
(xA(t) + xA(t)× α + xB(t)× β)
=
1
2
(1 + α)xA(t) +
1
2
(1− xA(t))β
=
1 + α− β
2
xA(t) +
β
2
.
With the law of total expectation we obtain Eq. (1) as follows
µt+1 = E(xA(t)) = E(E(xA(t + 1)|xA(t))) =
1 + α− β
2
µt +
β
2
.
For the conditional variance of xA(t),
V ar(xA(t + 1)|xA(t)) = V ar(
nA(t+ 1)
N(t + 1)
|xA(t))
= V ar(
nA(t) +
∑nA(t)
i=1 ξi +
∑nB(t)
i=1 ηi
N(t + 1)
|xA(t))
= V ar(
∑nA(t)
i=1 ξi +
∑nB(t)
i=1 ηi
N0 × 2t+1
|xA(t))
=
1
N20 × 2
2t+2
(nA(t)α(1− α) + nB(t)β(1− β))
=
1
N0 × 2t+2
(
nA(t)
N0 × 2t
α(1− α) +
nB(t)
N0 × 2t
β(1− β))
=
1
N0 × 2t+2
(xA(t)α(1− α) + xB(t)β(1− β))
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With the law of total variance we obtain Eq. (2) as follows
σ2t+1 = V ar(E(xA(t+ 1)|xA(t))) + E(V ar(xA(t+ 1)|xA(t)))
= (
1 + α− β
2
)2σ2t +
1
N0 × 2t+2
{[α(1− α)− β(1− β)]µt + β(1− β)} .
B An example of simulation results
We select one simulation from each of the 20 parameters settings in Simulations I&II, and
show an example of estimation results in Figure 1.
C Point estimation of real data
Here we show point estimation results of real data for different models.
Model α β
Θ1 0.978 0.125
Θ2 0.990 0.118
Θ3 0.890 0.008
Θ4 0.991 0.014
Θ1 = Θ2 0.987 0.121
Θ1 = Θ3 0.889 0.056
Θ1 = Θ4 0.992 0.031
Θ2 = Θ3 0.899 0.072
Θ2 = Θ4 0.993 0.036
Θ3 = Θ4 0.902 0.064
Θ1 = Θ2 = Θ3 0.882 0.154
Θ1 = Θ2 = Θ4 0.996 0.042
Θ1 = Θ3 = Θ4 0.888 0.131
Θ2 = Θ3 = Θ4 0.900 0.116
Θ1 = Θ2 = Θ3 = Θ4 0.892 0.152
Table 4: Parameter estimation of different models. Θi represents the estimation of pa-
rameters of i-th group in real data and Θi1 = · · · = Θik represents estimation of common
parameters within these k groups.
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(d) Simulation II with N0: β
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(e) Simulation II withoutN0: α
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(f) Simulation II withoutN0: β
Figure 1: An example of estimation results in Simulation I and Simulation II. Black solid
lines represent true values of parameters and red lines represent point estimation. And
two dashed lines demonstrate interval estimations. For Simulation II, both the estimation
results with and withoutN0 are shown
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